接种肉芽肿及铝接触过敏儿童口服铝激发后不良反应研究
15名3-9岁(平均5岁)伴接种肉芽肿且氯化铝六水合物2%/10%凡士林斑贴试验阳性的儿童,完成3周盲法随机对照交叉口服铝/安慰剂煎饼激发研究。铝激发期肉芽肿瘙痒VAS评分1.5 vs 安慰剂期1.4(p=0.6),其他主观症状0.6 vs 0.6(p=1),睡眠模式无差异,尿铝排泄与症状严重程度无显著相关;3名儿童在铝激发第4天出现面部或臀部对称性皮疹而安慰剂期未出现。作者结论:口服铝摄入与主观症状及肉芽肿瘙痒的发生无差异,但个案层面口服铝可能与系统性接触性皮炎的发生相关。
要点
- 铝激发期肉芽肿瘙痒VAS 1.5 vs 安慰剂期1.4(p=0.6),无显著差异。
- 其他主观症状VAS 0.6 vs 0.6(p=1),睡眠模式无差异。
- 3名儿童铝激发第4天出现面部或臀部对称性皮疹,安慰剂期未出现。
核心结论
- 口服铝摄入与主观症状及肉芽肿瘙痒的发生无差异,但个案层面口服铝可能与系统性接触性皮炎的发生相关。
研究设计与样本
- 3周盲法随机对照交叉口服铝/安慰剂煎饼激发研究,纳入15名3-9岁(平均5岁)伴接种肉芽肿且氯化铝六水合物2%/10%凡士林斑贴试验阳性的儿童,儿童作为自身对照。
主要发现
- 铝激发期肉芽肿瘙痒平均VAS 1.5 vs 安慰剂期1.4(p=0.6)。
- 铝激发期其他主观症状平均VAS 0.6 vs 安慰剂期0.6(p=1)。
- 睡眠模式无差异,尿铝排泄与症状严重程度无显著相关。
- 3名儿童在铝激发第4天出现面部或臀部对称性皮疹,安慰剂激发期未出现。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: According to their parents, some children with aluminium contact allergy and vaccination granulomas may react to aluminium-containing foods by developing dermatitis, granuloma itch and subjective symptoms. OBJECTIVES: The objective of this study is to determine whether oral intake of aluminium-containing pancakes can cause adverse events and/or systemic contact dermatitis (SCD) in children with vaccination granulomas and aluminium contact allergy. PATIENTS/METHODS: A total of 15 children aged 3-9 years (mean age, 5 years) with vaccination granulomas and positive patch-test results to aluminium chloride hexahydrate 2%/10% pet. completed a 3-week blinded randomized controlled crossover oral aluminium/placebo provocation study with pancakes. Granuloma itch and other subjective symptoms were evaluated daily on a visual analogue scale (VAS). Dermatitis was evaluated by the primary investigator, and sleep patterns were tracked with an electronic device. Aluminium bioavailability was assessed by measuring aluminium excretion in the urine. The children served as their own controls with the placebo provocations. RESULTS: All 15 children completed the study. The mean VAS scores were slightly higher during aluminium provocations compared with placebo for granuloma itch (mean VAS, 1.5 vs. 1.4, p = 0.6) but identical for other subjective symptoms (0.6 vs. 0.6, p = 1). There were no differences in sleep patterns and no significant correlation between urinary aluminium excretion and symptom severity. Three children developed a symmetrical rash on the face or buttocks on day 4 of the aluminium provocations, but not during placebo provocations. CONCLUSIONS: No difference was found between oral aluminium intake and the occurrence of subjective symptoms and granuloma itch, but on a case-basis oral aluminium may be associated with the development of systemic contact dermatitis.
引用
- Hoffmann SS, Elberling J, Skamstrup Hansen K, et al. Adverse reactions after oral provocation with aluminium in children with vaccination granulomas and aluminium contact allergy. J Eur Acad Dermatol Venereol. 2023. PMID: 36478462. doi:10.1111/jdv.18811
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。